
    
      Pharmacokinetics of rifampin, ticarcillin-clavulanate, and clindamycin antibiotics in
      hospitalized infants with suspected systemic infection or receiving one of the study drugs
      per local standard of care. Number of participants are 16-32 evaluable per each study drug of
      rifampin, ticarcillin-clavulanate, and clindamycin antibiotics.
    
  